Exact Mass: 529.2246
Exact Mass Matches: 529.2246
Found 500 metabolites which its exact mass value is equals to given mass value 529.2246
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Malformin
Malformin is produced by Aspergillus niger. It is isolated from mould damaged ric
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-D-Galactose
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-D-Galactose is a milk oligosaccharide alditol derived from mucin glycoprotein detected with High-performance anion exchange-chromatography. (PMID: 1799211). This oligosaccharide alditol is also found in purified human bronchial mucins. (PMID: 1337867) This O-glycan is present in normal human mucins along the intestinal tract. (PMID: 15361072). O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-D-Galactose is a milk oligosaccharide alditol derived from mucin glycoprotein detected with High-performance anion exchange-chromatography. (PMID: 1799211)
Lewis X trisaccharide
Lewis X trisaccharide is a common oligosaccharide involved in the terminal glycosylation of oligosaccharide chains of glycoconjugates and as such play a major role in the antigenic properties of cell surfaces and in the changing carbohydrates profiles that occur on cell maturation and in malignancy. Lewis X present in human milk can bind to DC-specific ICAM3-grabbing non-integrin and thereby prevent the capture and subsequent transfer of HIV-1 to CD4+ T lymphocytes. The presence of such a DC-specific ICAM3-grabbing non-integrin-binding molecule in human milk may both influence antigenic presentation and interfere with pathogen transfer in breastfed infants. Lewis X is a promising urine marker for bladder cancer surveillance in urothelial cell carcinoma patients. (PMID: 11278542; 11300757; 15184372; 15242599; 15845541; 16239964; 16773661; 9490204, 16217395) [HMDB] Lewis X trisaccharide is a common oligosaccharide involved in the terminal glycosylation of oligosaccharide chains of glycoconjugates and as such play a major role in the antigenic properties of cell surfaces and in the changing carbohydrates profiles that occur on cell maturation and in malignancy. Lewis X present in human milk can bind to DC-specific ICAM3-grabbing non-integrin and thereby prevent the capture and subsequent transfer of HIV-1 to CD4+ T lymphocytes. The presence of such a DC-specific ICAM3-grabbing non-integrin-binding molecule in human milk may both influence antigenic presentation and interfere with pathogen transfer in breastfed infants. Lewis X is a promising urine marker for bladder cancer surveillance in urothelial cell carcinoma patients. (PMID: 11278542; 11300757; 15184372; 15242599; 15845541; 16239964; 16773661; 9490204, 16217395).
Lewis a trisaccharide
Lewis a trisaccharide is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Moderate-to-severe diarrhea of all causes occurs less often in infants whose milk contains high levels of total 2-linked fucosyloligosaccharides as a percent of milk oligosaccharide. The trisaccharide Lewis a trisaccharide is identical with the structure for the specific determinant in Lea substance, and strongly inhibits the agglutination of Lea erythrocytes by a human anti-Lea serum. (PMID: 15343178, 17375110, 12568665, 2503806; 3809884; 6809837; 6880139; 7701811; 8662894; 8914840; 8943285) [HMDB] Lewis a trisaccharide is a fucosyloligosaccharide present in human milk and colostrum. Human colostrum is known to be important for the protection of infants against infection by pathogenic microorganisms. This protection is thought to be due, partially, to various neutral and acidic oligosaccharides that are present in colostrum and milk. Moderate-to-severe diarrhea of all causes occurs less often in infants whose milk contains high levels of total 2-linked fucosyloligosaccharides as a percent of milk oligosaccharide. The trisaccharide Lewis a trisaccharide is identical with the structure for the specific determinant in Lea substance, and strongly inhibits the agglutination of Lea erythrocytes by a human anti-Lea serum. (PMID: 15343178, 17375110, 12568665, 2503806; 3809884; 6809837; 6880139; 7701811; 8662894; 8914840; 8943285).
alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-D-Galp
a-Trisaccharide
Galbeta1-3(Fucalpha1-4)GlcNAcbeta
Globo-H
H Type II trisaccharide
Pegnivacogin
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
3-[4-[2-[[6-Amino-9-[(2R,3R,4S,5S)-5-[[ethyl(formyl)amino]-hydroxymethyl]-3,4-dihydroxyoxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid
(2R)-2-Acetyl-1-[(2S)-2-[acetyl-[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylic acid
Kapporphin
Derived from the kappa-chain of immunoglobulin
(Z)-N6-(5-(3-((1-carboxy-2-(4-hydroxyphenyl)ethyl)amino)-2-methoxy-3-oxoprop-1-en-1-yl)-2-hydroxybenzoyl)lysine
(1S,4S,7R,10S,13S)-7,10-di(butan-2-yl)-4-propan-2-yl-15,16-dithia-3,6,9,12,18-pentazabicyclo[11.4.2]nonadecane-2,5,8,11,19-pentone
(1S,4S,7R,10S,13S)-7,10-di(butan-2-yl)-4-propan-2-yl-15,16-dithia-3,6,9,12,18-pentazabicyclo[11.4.2]nonadecane-2,5,8,11,19-pentone [IIN-based: Match]
(1S,4S,7R,10S,13S)-7,10-di(butan-2-yl)-4-propan-2-yl-15,16-dithia-3,6,9,12,18-pentazabicyclo[11.4.2]nonadecane-2,5,8,11,19-pentone [IIN-based on: CCMSLIB00000848487]
Ala Asn Tyr Tyr
Ala Tyr Asn Tyr
Ala Tyr Tyr Asn
Cys Asp His Arg
Cys Asp Arg His
Cys Phe Phe Asn
Cys Phe Asn Phe
Cys His Asp Arg
Cys His Arg Asp
Cys Asn Phe Phe
Cys Arg Asp His
Cys Arg His Asp
Asp Cys His Arg
Asp Cys Arg His
Asp His Cys Arg
Asp His Lys Met
Asp His Met Lys
Asp His Arg Cys
Asp Ile Pro Trp
Asp Ile Trp Pro
Asp Lys His Met
Asp Lys Met His
Asp Leu Pro Trp
Asp Leu Trp Pro
Asp Met His Lys
Asp Met Lys His
Asp Pro Ile Trp
Asp Pro Leu Trp
Asp Pro Trp Ile
Asp Pro Trp Leu
Asp Arg Cys His
Asp Arg His Cys
Asp Trp Ile Pro
Asp Trp Leu Pro
Asp Trp Pro Ile
Asp Trp Pro Leu
Glu Glu Pro Arg
Glu Glu Arg Pro
Glu Pro Glu Arg
Glu Pro Arg Glu
Glu Pro Val Trp
Glu Pro Trp Val
Glu Arg Glu Pro
Glu Arg Pro Glu
Glu Val Pro Trp
Glu Val Trp Pro
Glu Trp Pro Val
Glu Trp Val Pro
Phe Cys Phe Asn
Phe Cys Asn Phe
Phe Phe Cys Asn
Phe Phe Asn Cys
Phe Asn Cys Phe
Phe Asn Phe Cys
Phe Asn Ser Tyr
Phe Asn Tyr Ser
Phe Ser Asn Tyr
Phe Ser Tyr Asn
Phe Tyr Asn Ser
Phe Tyr Ser Asn
Gly His Met Trp
Gly His Trp Met
Gly Lys Tyr Tyr
Gly Met His Trp
Gly Met Trp His
Gly Gln Tyr Tyr
Gly Trp His Met
Gly Trp Met His
Gly Tyr Lys Tyr
Gly Tyr Gln Tyr
Gly Tyr Tyr Lys
Gly Tyr Tyr Gln
His Cys Asp Arg
His Cys Arg Asp
His Asp Cys Arg
His Asp Lys Met
His Asp Met Lys
His Asp Arg Cys
His Gly Met Trp
His Gly Trp Met
His Lys Asp Met
His Lys Met Asp
His Met Asp Lys
His Met Gly Trp
His Met Lys Asp
His Met Arg Ser
His Met Ser Arg
His Met Trp Gly
His Asn Pro Tyr
His Asn Tyr Pro
His Pro Asn Tyr
His Pro Tyr Asn
His Arg Cys Asp
His Arg Asp Cys
His Arg Met Ser
His Arg Ser Met
His Ser Met Arg
His Ser Arg Met
His Ser Thr Trp
His Ser Trp Thr
His Thr Ser Trp
His Thr Trp Ser
His Trp Gly Met
His Trp Met Gly
His Trp Ser Thr
His Trp Thr Ser
His Tyr Asn Pro
His Tyr Pro Asn
Ile Asp Pro Trp
Ile Asp Trp Pro
Ile Pro Asp Trp
Ile Pro Trp Asp
Ile Trp Asp Pro
Ile Trp Pro Asp
Lys Asp His Met
Lys Asp Met His
Lys Gly Tyr Tyr
Lys His Asp Met
Lys His Met Asp
Lys Met Asp His
Lys Met His Asp
Lys Tyr Gly Tyr
Lys Tyr Tyr Gly
Leu Asp Pro Trp
Leu Asp Trp Pro
Leu Pro Asp Trp
Leu Pro Trp Asp
Leu Trp Asp Pro
Leu Trp Pro Asp
Met Asp His Lys
Met Asp Lys His
Met Gly His Trp
Met Gly Trp His
Met His Asp Lys
Met His Gly Trp
Met His Lys Asp
Met His Arg Ser
Met His Ser Arg
Met His Trp Gly
Met Lys Asp His
Met Lys His Asp
Met Pro Pro Trp
Met Pro Trp Pro
Met Arg His Ser
Met Arg Ser His
Met Ser His Arg
Met Ser Arg His
Met Trp Gly His
Met Trp His Gly
Met Trp Pro Pro
Asn Ala Tyr Tyr
Asn Cys Phe Phe
Asn Phe Cys Phe
Asn Phe Phe Cys
Asn Phe Ser Tyr
Asn Phe Tyr Ser
Asn His Pro Tyr
Asn His Tyr Pro
Asn Asn Pro Trp
Asn Asn Trp Pro
Asn Pro His Tyr
Asn Pro Asn Trp
Asn Pro Trp Asn
Asn Pro Tyr His
Asn Ser Phe Tyr
Asn Ser Tyr Phe
Asn Trp Asn Pro
Asn Trp Pro Asn
Asn Tyr Ala Tyr
Asn Tyr Phe Ser
Asn Tyr His Pro
Asn Tyr Pro His
Asn Tyr Ser Phe
Asn Tyr Tyr Ala
Pro Asp Ile Trp
Pro Asp Leu Trp
Pro Asp Trp Ile
Pro Asp Trp Leu
Pro Glu Glu Arg
Pro Glu Arg Glu
Pro Glu Val Trp
Pro Glu Trp Val
Pro His Asn Tyr
Pro His Tyr Asn
Pro Ile Asp Trp
Pro Ile Trp Asp
Pro Leu Asp Trp
Pro Leu Trp Asp
Pro Met Pro Trp
Pro Met Trp Pro
Pro Asn His Tyr
Pro Asn Asn Trp
Pro Asn Trp Asn
Pro Asn Tyr His
Pro Pro Met Trp
Pro Pro Trp Met
Pro Arg Glu Glu
Pro Val Glu Trp
Pro Val Trp Glu
Pro Trp Asp Ile
Pro Trp Asp Leu
Pro Trp Glu Val
Pro Trp Ile Asp
Pro Trp Leu Asp
Pro Trp Met Pro
Pro Trp Asn Asn
Pro Trp Pro Met
Pro Tyr His Asn
Pro Tyr Asn His
Gln Gly Tyr Tyr
Gln Tyr Gly Tyr
Gln Tyr Tyr Gly
Arg Cys Asp His
Arg Cys His Asp
Arg Asp Cys His
Arg Asp His Cys
Arg Glu Glu Pro
Arg Glu Pro Glu
Arg His Cys Asp
Arg His Asp Cys
Arg His Met Ser
Arg His Ser Met
Arg Met His Ser
Arg Met Ser His
Arg Pro Glu Glu
Arg Ser His Met
Arg Ser Met His
Ser Phe Asn Tyr
Ser Phe Tyr Asn
Ser His Met Arg
Ser His Arg Met
Ser His Thr Trp
Ser His Trp Thr
Ser Met His Arg
Ser Met Arg His
Ser Asn Phe Tyr
Ser Asn Tyr Phe
Ser Arg His Met
Ser Arg Met His
Ser Thr His Trp
Ser Thr Trp His
Ser Trp His Thr
Ser Trp Thr His
Ser Tyr Phe Asn
Ser Tyr Asn Phe
Thr His Ser Trp
Thr His Trp Ser
Thr Ser His Trp
Thr Ser Trp His
Thr Trp His Ser
Thr Trp Ser His
Trp Gly His Met
Trp Gly Met His
Trp His Gly Met
Trp His Met Gly
Trp His Ser Thr
Trp His Thr Ser
Trp Met Gly His
Trp Met His Gly
Trp Met Pro Pro
Trp Asn Asn Pro
Trp Asn Pro Asn
Trp Pro Met Pro
Trp Pro Asn Asn
Trp Pro Pro Met
Trp Ser His Thr
Trp Ser Thr His
Trp Thr His Ser
Trp Thr Ser His
Tyr Ala Asn Tyr
Tyr Ala Tyr Asn
Tyr Phe Asn Ser
Tyr Phe Ser Asn
Tyr Gly Gln Tyr
Tyr Gly Tyr Gln
Tyr His Asn Pro
Tyr His Pro Asn
Tyr Asn Ala Tyr
Tyr Asn Phe Ser
Tyr Asn His Pro
Tyr Asn Pro His
Tyr Asn Ser Phe
Tyr Asn Tyr Ala
Tyr Pro His Asn
Tyr Pro Asn His
Tyr Gln Gly Tyr
Tyr Gln Tyr Gly
Tyr Ser Phe Asn
Tyr Ser Asn Phe
Tyr Tyr Ala Asn
Tyr Tyr Gly Gln
Tyr Tyr Asn Ala
Tyr Tyr Gln Gly
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-D-Galactose
Lewis X
Lea tri
Malformin
Malformin-B4
7-[2-(diethylamino)ethyl]-1,3-dimethylpurine-2,6-dione,2-(7-hydroxy-4-methyl-2-oxochromen-6-yl)oxyacetic acid
(+)-(3r,4r)-bis(diphenylphosphino)-1-benzylpyrrolidine
ezatiostat
C471 - Enzyme Inhibitor > C2137 - Glutathione Transferase Inhibitor Ezatiostat (TER199 free base; TLK199) is a tripeptide analog of glutathione and is a selective and orally active glutathione S-transferase P1-1 (GSTP1) inhibitor. Ezatiostat leads to JNK activation by inhibiting GSTP1. Ezatiostat stimulates both lymphocyte production and bone marrow progenitor proliferation. Ezatiostat has the potential for myelodysplastic syndrome (MDS) treatment[1][2].
1-propanesulfonic acid 3,3-(hexadecylimino) bisdisodium salt
O-6-Deoxy-beta-L-galactopyranosyl-(1-2)-O-beta-D-galactopyranosyl-(1-3)-2-(acetylamino)-2-deoxy-D-glucose
6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-glucopyranose
alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-D-Galp
2-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[(1R,2R)-2-methoxy-1-[[(2S)-1-methylpyrrolidin-1-ium-2-carbonyl]amino]propyl]oxan-2-yl]sulfanylethyl 2-hydroxybenzoate
3-[4-[2-[[6-Amino-9-[(2R,3R,4S,5S)-5-[[ethyl(formyl)amino]-hydroxymethyl]-3,4-dihydroxyoxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid
(2R)-2-Acetyl-1-[(2S)-2-[acetyl-[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylic acid
N-[4,5-dihydroxy-6-(hydroxymethyl)-2-[4,5,6-trihydroxy-1-oxo-2-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyhexan-3-yl]oxyoxan-3-yl]acetamide
NSC 23766 trihydrochloride
NSC 23766 trihydrochloride is an inhibitor of Rac1 activation.